Economic Impact of Migraines

Migraine is a severe form of headache and symptoms can last anything form a few hours to a few days, with some individuals affected on a regular basis for the whole of their lives.

There have been several studies examining the cost of migraine attacks on the economy, in terms of both medical costs and lost productivity.

Nearly 12% to 28% of the world’s adult population suffers from migraine at some point in life. In the United Kingdom, one in four women and one in 12 men are migraine sufferers.

In the European community, the cost of migraine attacks is estimated to be more than €27 billion per year. In the United states, the cost has been estimated at $17 billion. Almost a tenth of this cost is accounted for by the use of triptans to relieve symptoms, while $15 billion is accounted for by indirect costs such as work absenteeism. Among individuals who do attend work with a migraine, effectiveness at work is decreased by about a third.

One study showed that in 2000, migraine accounted for an average of 8.3 days absenteeism and 11.2 days of reduced productivity per individual each year, with an overall estimated cost to employers of US$ 3,309 per sufferer.

In the United Kingdom, migraine costs the National Health Service (NHS) around £20 to 30 million per year and forms around 0.1% of total NHS expenditure. In fact, migraine accounts for 25% of all annual sicknesses per head in the manufacturing industry and forms around 20% of the annual sick leave under the NHS in the UK.

Further Reading

Last Updated: Jul 14, 2023

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.


Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2023, July 14). Economic Impact of Migraines. News-Medical. Retrieved on July 24, 2024 from

  • MLA

    Mandal, Ananya. "Economic Impact of Migraines". News-Medical. 24 July 2024. <>.

  • Chicago

    Mandal, Ananya. "Economic Impact of Migraines". News-Medical. (accessed July 24, 2024).

  • Harvard

    Mandal, Ananya. 2023. Economic Impact of Migraines. News-Medical, viewed 24 July 2024,


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Atogepant may decrease the risk of developing rebound headache in people with migraine